Highlights Magle Chemoswed Holding AB

Equities

MAGLE

SE0014401014

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
40.4 ^SEK	-4.27%		-0.98%	+60.32%

Jun. 28	Magle Chemoswed Finalizes Agreement for pK Chemicals, pK Biotech Acquisition	MT
Jun. 17	Magle Chemoswed Holding AB Announces Increasing Production Capacity	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Magle Chemoswed Finalizes Agreement for pK Chemicals, pK Biotech Acquisition	Jun. 28	MT
Magle Chemoswed Holding AB Announces Increasing Production Capacity	Jun. 17	CI
Magle Chemoswed Holding AB (OM:MAGLE) signed a binding term sheet to acquire Pk Biotech Aps from Prs1 Aps for SEK 240 million.	Jun. 16	CI
Magle Chemoswed Holding AB (OM:MAGLE) cancelled the acquisition of 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other.	May. 19	CI
Magle Chemoswed Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Magle Chemoswed Holding AB Resolves to Withdraws Dividend Proposal for the Year 2023	Mar. 22	CI
Magle Chemoswed Holding AB (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million.	Mar. 21	CI
Magle Chemoswed Holding AB Proposes Dividend for the Fiscal Year 2023	Feb. 16	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 16	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 16	CI
Magle Group Enters Collaboration with Sirtex Medical to Support the International Commercialization of Embocept S Dsm 50 Um	23-09-08	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-29	CI
Magle Chemoswed Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-29	CI
Magle Group Announces Positive Results from Post-Market Clinical Follow-Up of SmartPAN	23-04-27	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-16	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-16	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-16	CI
Magle Chemoswed Holding AB 's Proprietary Product Axxo® Woundgel Receives Regulatory Approval in Kuwait	22-11-21	CI
Magle Group's Vascular Embolic Product Embocept® S Receives Regulatory Approval in Argentina	22-11-17	CI
Magle Chemoswed Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Magle Chemoswed Holding AB

Equities

MAGLE

SE0014401014

Highlights

Filters